Catalog Number 02G22-30 |
Device Problem
False Negative Result (1225)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 04/27/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
There was no further patient information provided by the customer.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 2g22 that has a similar product distributed in the us, list number 4p53.
|
|
Event Description
|
The customer observed false nonreactive architect (b)(6) qualitative ii results on one patient.The results were provided: on (b)(6) 2020 sid (b)(6) initial (b)(6) result=0.7497 s/co ( <1.00 s/co= nonreactive) / (previous history=(b)(6) reactive last year) / on (b)(6) 2020 repeated results= 0.7276 s/co ( nonreactive) and 140.4914 s/co (> or =1.00 s/ co=reactive) / confirmatory result c1=0.1067 s/co (na), c2=0.7080 s/co (reactive), n%=114.8148 (confirmed positive).
|
|
Manufacturer Narrative
|
A review of tickets was performed for reagent architect hbsag qualitative ii lot number 04361fn00.The ticket search determined that there is normal complaint activity for the likely cause lot.A review of tracking and trending did not identify any trends for the complaint issue.Return testing was not completed as returns were not available.Historical performance of reagent lot 04361fn00 was evaluated using world wide data from abbottlink.This evaluation indicated that the patient median result for lot 04361fn00 is within the established baseline and comparable with other lot number in the field.Therefore, no unusual reagent lot performance was identified.A review of the manufacturing documentation did not identify any issues associated with the complaint issue.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the architect hbsag qualitative ii, lot 04361fn00.
|
|
Search Alerts/Recalls
|